Alinezhad Shebilouysofla, Parinaz
Mostafa Gharebaghi, Manizheh
Sattarzadeh Jahdi, Niloufar
Abdoli Najmi, Leila
Hakimi, Sevil
Article History
Received: 26 September 2022
Accepted: 11 November 2022
First Online: 22 November 2022
Declarations
:
: Ethics approval and consent to participate this protocol have been approved by the Ethics Committee of Tabriz University of Medical Sciences, Tabriz, Iran (reference number: IR.TBZMED.REC.1399.819). And this trial has also been registered on IRCT and received the code IRCT20150424021917N11. Written informed consent was obtained from the parents, who agree to participate in the study. All methods were performed in accordance with the relevant guidelines as regulations.
: Not applicable.
: The authors declare that they have no competing interests.